FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1151.5.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1151.5/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5 |
| Version | 20160713 |
| Status | active |
| Date | 2016-07-13T01:00:02-04:00 |
| Name | BCGBacillusCalmetteGuerinConnaught |
| Title | BCG Bacillus Calmette Guerin, Connaught |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: BCG is used for the treatment of non muscle invasive bladder cancer and is administered intravesically.),(Data Element Scope: The intent of this data element is to include BCG as a treatment for non muscle invasive bladder cancer),(Inclusion Criteria: Bacillus Calmette Guerin for intravesical use),(Exclusion Criteria: None) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1151.5",
"meta": {
"versionId": "3",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Oregon Urology Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-02-08"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2016-07-13"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1151.5"
}
],
"version": "20160713",
"name": "BCGBacillusCalmetteGuerinConnaught",
"title": "BCG Bacillus Calmette Guerin, Connaught",
"status": "active",
"experimental": false,
"date": "2016-07-13T01:00:02-04:00",
"publisher": "Oregon Urology Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: BCG is used for the treatment of non muscle invasive bladder cancer and is administered intravesically.),(Data Element Scope: The intent of this data element is to include BCG as a treatment for non muscle invasive bladder cancer),(Inclusion Criteria: Bacillus Calmette Guerin for intravesical use),(Exclusion Criteria: None)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "76469",
"display": "BCG, Live, Connaught Strain"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:4b6cc8cb-5911-4300-89ae-f0f3d83724e1",
"timestamp": "2025-05-23T18:58:52-04:00",
"total": 1,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "76469",
"display": "BCG, live, Connaught strain"
}
]
}
}